Journal article 1355 views
In Vitro Inhibition of Human Aldehyde Oxidase Activity by Clinically Relevant Concentrations of Gefitinib and Erlotinib: Comparison with Select Metabolites, Molecular Docking Analysis, and Impact on Hepatic Metabolism of Zaleplon...
,
Aik Jiang Lau
Journal of Pharmacology and Experimental Therapeutics, Volume: 374, Issue: 2, Pages: 295 - 307
Swansea University Authors:
Karl Austin-Muttitt, Jonathan Mullins
Full text not available from this repository: check for access using links below.
DOI (Published version): 10.1124/jpet.120.265249
Abstract
In Vitro Inhibition of Human Aldehyde Oxidase Activity by Clinically Relevant Concentrations of Gefitinib and Erlotinib: Comparison with Select Metabolites, Molecular Docking Analysis, and Impact on Hepatic Metabolism of Zaleplon and Methotrexate
| Published in: | Journal of Pharmacology and Experimental Therapeutics |
|---|---|
| ISSN: | 0022-3565 1521-0103 |
| Published: |
American Society for Pharmacology & Experimental Therapeutics (ASPET)
2020
|
| Online Access: |
Check full text
|
| URI: | https://cronfa.swan.ac.uk/Record/cronfa55640 |
| College: |
Faculty of Medicine, Health and Life Sciences |
|---|---|
| Issue: |
2 |
| Start Page: |
295 |
| End Page: |
307 |